Dr. Victoria Forte has been appointed chief of the Division of Hematology/Oncology, Cancer Service Line director, and ...

Adjuvant ado-trastuzumab emtansine significantly prolonged survival compared with trastuzumab for certain women with ...

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients ...

A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in ...

An affiliate of a major developer has bought land near Crossgates where there's a plan to build a regional cancer treatment ...

Healio will present its fourth annual Disruptive Innovators Awards for oncology/hematology this spring. The Dobbs v. Jackson Women’s Health Association decision continues to have a significant ...

Drs. Kuang S. Chang, Frederick L. Flynt Jr., Jonathan Hsu, and Ashley Ray receive peer-driven honorATHENS, Ga., Jan. 15, 2025 (GLOBE NEWSWIRE) ...

The FDA has banned Red Dye No. 3, citing cancer risk concerns. The removal from the supply chain may take over a year, raising questions about other additives.

Patients undergoing a donor stem-cell transplant for leukemia or other blood-related cancer require months of specialized ...

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and ...